EDESA BIOTECH, INC. Sales Revenue, Goods, Net (Deprecated 2018-01-31)
EDESA BIOTECH, INC. (EDSA) reported Sales Revenue, Goods, Net (Deprecated 2018-01-31) of $64.05 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SalesRevenueGoodsNet · last filed 2018-05-07
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $64.05K, a 391.99% increase year-over-year.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $20.49K, a 85.56% decline year-over-year.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $2.88K, a 98.96% decline year-over-year.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $20.53K, a 88.66% decline year-over-year.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2017 was $178.29K, a 85.62% decline from fiscal 2016.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2016 was $1.24M, a 119.92% increase from fiscal 2015.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2015 was $563.69K, a 292.67% increase from fiscal 2014.
- EDESA BIOTECH, INC. sales revenue, goods, net (deprecated 2018-01-31) for fiscal 2014 was $143.55K, a 88.75% increase from fiscal 2013.
| Period end | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 1 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 3 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 6 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 9 month | Sales Revenue, Goods, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | $64.05K 10-Q · filed 2018-05-07 | $84.54K 10-Q · filed 2018-05-07 | $87.42K derived: sum of 3 quarters · filed 2018-05-07 | $107.95K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2017-12-31 | $20.49K 10-Q · filed 2018-02-07 | $23.37K derived: sum of 2 quarters · filed 2018-02-07 | $43.90K derived: sum of 3 quarters · filed 2018-02-07 | $56.92K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2017-09-30 | $2.88K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $23.41K derived: sum of 2 quarters · filed 2017-12-01 | $36.43K derived: sum of 3 quarters · filed 2018-05-07 | $178.29K 10-K · filed 2017-12-01 | |
| 2017-06-30 | $20.53K 10-Q · filed 2017-08-09 | $33.55K derived: sum of 2 quarters · filed 2018-05-07 | $175.41K 10-Q · filed 2017-08-09 | $451.51K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2017-03-31 | $13.02K 10-Q · filed 2018-05-07 | $154.88K 10-Q · filed 2018-05-07 | $430.98K derived: sum of 3 quarters · filed 2018-05-07 | $612.07K derived: sum of 4 quarters · filed 2018-05-07 | |
| 2016-12-31 | $141.86K 10-Q · filed 2018-02-07 | $417.96K derived: sum of 2 quarters · filed 2018-02-07 | $599.05K derived: sum of 3 quarters · filed 2018-02-07 | $925.38K derived: sum of 4 quarters · filed 2018-02-07 | |
| 2016-09-30 | $276.10K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $457.19K derived: sum of 2 quarters · filed 2017-12-01 | $783.53K derived: sum of 3 quarters · filed 2017-12-01 | $1.24M 10-K · filed 2017-12-01 | |
| 2016-06-30 | $181.09K 10-Q · filed 2017-08-09 | $507.43K derived: sum of 2 quarters · filed 2017-08-09 | $963.59K 10-Q · filed 2017-08-09 | $1.12M derived: sum of 4 quarters · filed 2017-12-01 | |
| 2016-03-31 | $326.33K 10-Q · filed 2017-05-09 | $782.50K 10-Q · filed 2017-05-09 | $938.15K derived: sum of 3 quarters · filed 2017-12-01 | $1.05M derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-12-31 | $456.16K 10-Q · filed 2017-02-06 | $611.81K derived: sum of 2 quarters · filed 2017-12-01 | $724.56K derived: sum of 3 quarters · filed 2017-12-01 | $867.19K derived: sum of 4 quarters · filed 2017-12-01 | |
| 2015-09-30 | $155.65K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01 | $268.40K derived: sum of 2 quarters · filed 2017-12-01 | $411.03K derived: sum of 3 quarters · filed 2017-12-01 | $563.69K 10-K · filed 2017-12-01 | |
| 2015-06-30 | $112.75K 10-Q · filed 2016-08-09 | $255.38K derived: sum of 2 quarters · filed 2016-08-09 | $408.04K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $142.63K 10-Q · filed 2016-05-09 | $295.29K 10-Q · filed 2016-05-09 | |||
| 2014-12-31 | $152.66K 10-Q · filed 2016-02-08 | ||||
| 2014-09-30 | $32.79K 10-K · filed 2016-12-14 | ||||
| 2014-08-31 | $143.55K 10-K · filed 2016-12-14 | ||||
| 2014-06-30 | $12.54K 10-Q · filed 2015-08-10 | $54.91K derived: sum of 2 quarters · filed 2015-08-10 | $70.99K 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $42.37K 10-Q · filed 2015-05-11 | $58.46K 10-Q · filed 2015-05-11 | |||
| 2013-12-31 | $16.09K 10-Q · filed 2015-02-09 | ||||
| 2013-08-31 | $76.06K 10-K · filed 2015-12-14 | ||||
| 2012-08-31 | $131.82K 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |